Evidence map›Paper›PMID 41356534›Full record

ArticleJCEM case reports2026

A Rare Presentation of Myxedema Coma Complicated by Acute Coronary Syndrome Successfully Managed With Oral Levothyroxine.

Mengesha Akale Tekle, Buzayehu Taye Gulilat, Wubshet Abraham Alemu, Robel Tilahun Raru, Nahom Addisu Bekele

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mengesha Akale TekleDepartment of Internal Medicine, Arsi University College of Health Science, Asella 193, Ethiopia.ORCID https://orcid.org/0009-0008-7162-5784
Buzayehu Taye GulilatDepartment of Internal Medicine, Arsi University College of Health Science, Asella 193, Ethiopia.
Wubshet Abraham AlemuDepartment of Internal Medicine, Arsi University College of Health Science, Asella 193, Ethiopia.ORCID https://orcid.org/0009-0005-0134-8935
Robel Tilahun RaruMenelik II Comprehensive Specialized Hospital, Addis Ababa 1000, Ethiopia.ORCID https://orcid.org/0009-0003-9065-0049
Nahom Addisu BekeleYekatit 12 Hospital Medical College, Addis Ababa 01250, Ethiopia.ORCID https://orcid.org/0009-0001-3118-5162

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxedema coma is a rare, life-threatening complication of severe hypothyroidism. While cardiovascular manifestations such as bradycardia and pericardial effusion are common, acute coronary syndrome (ACS) as a presenting feature is exceedingly rare. We report the case of a 65-year-old man with underlying hypertension who presented with features of heart failure, altered mental status, and chest pain. He was found to have severe hypothyroidism with myxedema coma and concurrent ACS. In a resource-limited setting, he was successfully managed with oral levothyroxine alongside standard supportive measures. His condition gradually improved over the course of a week, with significant recovery noted at follow-up. This case illustrates a rare manifestation of myxedema coma complicated by ACS, successfully managed without intravenous thyroid hormone therapy. Both myxedema coma and ACS are life-threatening medical emergencies that require a high index of suspicion for timely diagnosis, especially when they occur simultaneously in a single patient. Delayed recognition and intervention significantly increase the risk of mortality.

Indexed as

acute coronary syndromehypothyroidismmedical emergencymyxedema coma

Identifiers

PMID41356534
PMCPMC12676000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.